Simultaneous administration of fluoxetine and simvastatin ameliorates lipid profile, improves brain level of neurotransmitters, and increases bioavailability of simvastatin
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Experimental Pharmacology"
DOI: 10.2147/jep.s128696
Abstract: Simvastatin (STT), a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, is widely prescribed for dyslipidemia, whereas fluoxetine (FLX) is the first-choice drug for the treatment of depression and anxiety. A recent report suggests that selective serotonin reuptake… read more here.
Keywords: lipid profile; simvastatin; level neurotransmitters; stt ... See more keywords